Australian Clinical Trials Alliance

What Australian Clinical Trials Alliance does

Australian Clinical Trials Alliance (ACTA) is the national peak body for Australia's investigator-led clinical trials sector. Established in 2016 and headquartered in Melbourne, ACTA operates as a private, membership-based not-for-profit connecting clinical trial networks, coordinating centres, and clinical quality registries with government policymakers, regulators (notably the TGA and NHMRC), and consumers. Its stated mission is to expand the capacity, capability, efficiency, and effectiveness of investigator-initiated trials and registries that generate evidence for health practitioners, policymakers, and consumers.

ACTA's product surface is a portfolio of coordination services rather than proprietary technology. Core offerings include nine Special Interest Groups covering statistics (STInG), health economics (HEAT SIG), adaptive platform trials (APTO SIG), clinical quality registries (CQR SIG), implementation science (TRIP SIG), coordinating centres (CC SIG), equity of access (REACT-SIG), network managers (SIGNet), and advocacy; an interactive Consumer Involvement and Engagement Toolkit; the Australian Teletrial Program partnership for regional and rural access; an annual Trial of the Year Awards program (with sub-categories for STInG Excellence in Statistics, HEAT, Consumer Involvement, and Clinical Quality Registries); an annual Clinical Trials and Registries Symposium and ACTA Summit; a curated Resources Library; and member-only directories (DSMB, Find-a-Statistician, Find-a-Health-Economist). ACTA does not develop proprietary software products or technology platforms; its outputs are frameworks, toolkits, guidance documents, and convening events.

Commercially, ACTA runs a community-led go-to-market anchored by subscription-style membership fees from networks, coordinating centres, and registries, supplemented by event registrations and industry sponsorships. Major sponsors and partners include MTAA, MTPConnect, Bellberry, Medicines Australia, NHMRC, the Department of Health and Aged Care, the TGA, NSW Office for Health and Medical Research, CT:IQ, the Australian Teletrial Program, and SAHMRI Registry Centre. ACTA reports no parent company, no subsidiaries, no funding rounds, and no AI/ML capabilities, and is governed by a Board and Advisory Council; it currently publishes annual reports (most recent 2024–2025).

Name

Australian Clinical Trials Alliance

Legal name

Australian Clinical Trials Alliance

Website

https://clinicaltrialsalliance.org.au

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

11–50 employees

Short description

Australian Clinical Trials Alliance is Australia's national peak body for the clinical trials sector, connecting clinical trial networks, coordinating centres, and clinical quality registries with government, regulators, and consumers through advocacy, special interest groups, awards, and shared resources.

Ownership category

akta.pro rank

Product category

Clinical Trials Sector Advocacy and Coordination

NAICS

Professional Organizations (813920), Professional Organizations (81392)

SIC

Services-Membership Organizations (8600)

akta.pro primary industry

Clinical Site Start-Up & Activation (Regulatory/Ethics/Contracts) (HLAGACAC)

akta.pro secondary industry

Clinical Quality Assurance (GCP QA, TMF/QMS oversight) (HLAGAKAI)

Keywords

• Clinical trials advocacy
• Clinical trial networks
• Clinical quality registries
• Investigator-led trials
• Clinical research coordination

Headquarters

HQ city

Melbourne

HQ country

Australia

HQ region

Oceania

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Membership fees: ACTA generates revenue through membership fees from clinical trial networks, coordinating centres, and clinical quality registries that join as members.
2. Event registrations and sponsorships: ACTA organises and hosts events including the annual Clinical Trials and Registries Symposium, Trial of the Year Awards ceremonies, webinars, workshops, and the ACTA Summit. Revenue is generated through event registrations and sponsorships from industry and government partners.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels7 records

Core offering

ACTA is the national peak body for Australia's clinical trials sector, providing membership-based advocacy, professional networking, and educational resources to clinical trial networks, coordinating centres, and clinical quality registries. It delivers Special Interest Groups, awards programs, annual symposia, and toolkits (such as the Consumer Involvement and Engagement Toolkit and the Australian Teletrial Program) to strengthen investigator-initiated clinical trials across Australia.

Product overview

Australian Clinical Trials Alliance (ACTA) is a national peak body for the clinical trials sector, operating as a membership-based organization rather than a traditional software product company. ACTA provides a portfolio of coordination services, professional networks, and resources including: the Consumer Involvement and Engagement Toolkit (interactive guidance platform), the Australian Teletrial Program (ATP) for regional/rural trial access, nine Special Interest Groups covering adaptive trials, registries, statistics, health economics, implementation science, and network management, an annual Trial of the Year Awards program, a Resources Library of tools and templates, directories for statisticians and health economists, and an annual Clinical Trials and Registries Symposium. These offerings work together to strengthen investigator-led clinical trials in Australia through advocacy, education, networking, and resource sharing.

Differentiator

Problem solved

Functional benefit

Products and services

• Consumer Involvement and Engagement Toolkit

Quantifiable outcome

• ProPSMA trial (2021 Trial of the Year): PSMA PET/CT demonstrated 92% accuracy vs 65% for conventional imaging in prostate cancer staging, changing treatment plans for 28% of patients vs 15% with conventional imaging.
• +2 more outcomes

Named customers5 records

Segments5 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Eleven partnerships are on record, tiered key, core and minor.

• Medical Technology Association of Australia (MTAA)keyStrategic or Co-development Partner · 23 January 2026ACTA and MTAA announced a new clinical trials partnership in January 2026 to strengthen collaboration between the investigator-led clinical trials sector and the medical technology industry in Australia.
• MTPConnectkeyGTM or Marketing PartnerMTPConnect is a key event partner and supporter of ACTA's National Tribute and Award Ceremony and other sector events. MTPConnect co-hosted the launch of the 'Clinical Trials in Australia' report at the 2021 ACTA ceremony and is a session sponsor.
• Bellberry LimitedkeyStrategic or Co-development PartnerBellberry is a long-standing event partner of ACTA, serving as a Gold Sponsor of the ACTA Summit and Clinical Trials 2020 National Tribute and Awards Ceremony, and as an event partner for the 2021 National Tribute and Award Ceremony.
• Medicines AustraliakeyGTM or Marketing PartnerMedicines Australia is an event partner and sponsor of ACTA's National Tribute and Awards Ceremony, having sponsored the 2020 ceremony and contributed to the 2021 collaborative event.
• Australian Teletrial Program (ATP)coreStrategic or Co-development PartnerACTA partnered with the Australian Teletrial Program to help develop Teletrials as a way to bring safe, cost-effective, and quality trials closer to home for many Australians. The project delivers capacity building and education for clinical trial networks and coordinating centres to help plan and run Teletrials across regional, rural, and remote sites in Australia and across all therapeutic areas.
• SAHMRI Registry CentrekeyStrategic or Co-development PartnerThe SAHMRI Registry Centre collaborates with ACTA's Clinical Quality Registry Special Interest Group (CQR SIG) and the broader sector. The collaboration includes the CQR Hub (joint project with Monash University), annual symposiums, the Australian Clinical Registry Annual Scientific Meeting, webinars, a sector newsletter 'The Benchmark', and participation in national consultations.
• National Health and Medical Research Council (NHMRC)coreOthersNHMRC is listed as a supporter of ACTA events and its CEO (Prof Anne Kelso AO) participates as a keynote speaker and presenter at ACTA events. NHMRC provides significant funding to investigator-initiated clinical trials in Australia.
• Department of Health and Aged CarecoreOthersThe Department of Health and Aged Care funds the National Clinical Quality Registry Program, under which multiple ACTA member registries and the SAHMRI Registry Centre operate. ACTA also receives grants and engages in policy consultations with the Department.
• Therapeutic Goods Administration (TGA)keyOthersACTA works with the TGA on regulatory matters affecting clinical trials, including GCP guidelines and regulation amendments. The TGA presented at ACTA webinars on ICH GCP E6 (R3) guidelines in April 2025.
• CT:IQ (Clinical Trials: Impact through Quality Improvement)keyStrategic or Co-development PartnerCT:IQ is a collaborative partner in ACTA's consumer involvement initiatives, including the development of the Consumer Involvement and Engagement Toolkit. CT:IQ is listed as an event supporter for the 2021 National Tribute and Award Ceremony.
• Australian GenomicsminorStrategic or Co-development PartnerAustralian Genomics coordinated the Involve Australia project to develop guidelines for community involvement in genomic research. ACTA promotes these guidelines through its resources library as a national clinical resource relevant to consumer engagement in clinical trials.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Health Research Authority (UK): UK public body that oversees health and social care research, including ethics approvals and trial governance. Comparable to ACTA's regulatory and policy engagement function, but operating as a government agency rather than independent peak body.

Regional players

• MTPConnect: Australian Medical Technologies and Pharmaceuticals Industry Growth Centre serving as a peak body and accelerator for the medtech, biotech, and pharma sector. Comparable to ACTA as an Australian sector-aggregator and event partner, though with a commercial industry orientation rather than investigator-led trial focus.
• NHMRC Clinical Trials Centre: Australian clinical trial coordinating centre at the University of Sydney that runs multicentre investigator-initiated trials. Comparable to ACTA's constituent members (coordinating centres), operating within Australia and overlapping on ACTA's STInG and HEAT SIG activity.

Direct peers

• Clinical Trials Transformation Initiative (CTTI): US-based multi-stakeholder organisation that convenes clinical trial sponsors, regulators, patients, and academic investigators to improve the design and conduct of clinical trials. Comparable to ACTA as a peak-body / coalition focused on investigator-driven trial improvement rather than commercial trial delivery.
• ARCS Australia: Australian professional association for people working in clinical research, providing training, certification, and continuing professional development across the clinical trials sector. Comparable to ACTA as a national Australian non-profit serving clinical research professionals with events, education, and member services.
• Praxis Australia: Australian not-for-profit promoting high-quality conduct of clinical trials through education, training, and resources for researchers, ethics committees, and trial coordinators. Closely comparable to ACTA in mission and Australian non-profit structure focused on investigator-initiated trial capability.
• NIHR Clinical Research Network: UK national clinical research infrastructure that coordinates investigator-initiated and commercial trials across therapeutic areas. Closely analogous to ACTA's role as the national connector for clinical trial networks, coordinating centres, and registries, but with broader operational funding.
• European Clinical Research Infrastructure Network (ECRIN): European non-profit that supports multinational clinical trial coordination across national trial networks in Europe. Comparable to ACTA in mission of coordinating investigator-led trials across geographies, but operating at a multi-country level rather than nationally.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/ACTA_org
• LinkedInlinkedin.com/company/australian-clinical-trials-alliance

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Australian Clinical Trials Alliance